{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:48:41Z","timestamp":1790790521864,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,15]]},"DOI":"10.7759\/cureus.107100","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:10:13Z","timestamp":1776269413000},"source":"Crossref","is-referenced-by-count":1,"title":["Recurrent Intra-abdominal Low-Grade Fibromyxoid Sarcoma Managed With Multivisceral Resections: A Case Report"],"prefix":"10.7759","author":[{"given":"Kiril","family":"Kirov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Presian","family":"Varbanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Mirinchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/88.5.615","article-title":"Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance","volume":"88","author":"Evans HL","year":"1987","unstructured":"Evans HL. Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987, 88:615-19. 10.1093\/ajcp\/88.5.615","journal-title":"Am J Clin Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2017.04.001","article-title":"Low-grade fibromyxoid sarcoma: clinical, morphologic and genetic features","volume":"28","author":"Mohamed M","year":"2017","unstructured":"Mohamed M, Fisher C, Thway K. Low-grade fibromyxoid sarcoma: clinical, morphologic and genetic features. Ann Diagn Pathol. 2017, 28:60-7. 10.1016\/j.anndiagpath.2017.04.001","journal-title":"Ann Diagn Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318210c268","article-title":"MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma","volume":"35","author":"Doyle LA","year":"2011","unstructured":"Doyle LA, M\u00f6ller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011, 35:733-41. 10.1097\/PAS.0b013e318210c268","journal-title":"Am J Surg Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20037","article-title":"The chimeric FUS\/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma","volume":"40","author":"Panagopoulos I","year":"2004","unstructured":"Panagopoulos I, Storlazzi CT, Fletcher CD, et al.. The chimeric FUS\/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma. Genes Chromosomes Cancer. 2004, 40:218-28. 10.1002\/gcc.20037","journal-title":"Genes Chromosomes Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700230","article-title":"Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS\/CREB3L1 fusion gene","volume":"85","author":"Mertens F","year":"2005","unstructured":"Mertens F, Fletcher CD, Antonescu CR, et al.. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS\/CREB3L1 fusion gene. Lab Invest. 2005, 85:408-15. 10.1038\/labinvest.3700230","journal-title":"Lab Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200010000-00004","article-title":"Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas","volume":"24","author":"Folpe AL","year":"2000","unstructured":"Folpe AL, Lane KL, Paull G, Weiss SW. Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000, 24:1353-60. 10.1097\/00000478-200010000-00004","journal-title":"Am J Surg Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182562bf8","article-title":"MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement","volume":"36","author":"Doyle LA","year":"2012","unstructured":"Doyle LA, Wang WL, Dal Cin P, et al.. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012, 36:1444-51. 10.1097\/PAS.0b013e3182562bf8","journal-title":"Am J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/256280","article-title":"Low-grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene","volume":"2013","author":"Maretty-Nielsen K","year":"2013","unstructured":"Maretty-Nielsen K, Baerentzen S, Keller J, Dyrop HB, Safwat A. Low-grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene. Sarcoma. 2013, 2013:256280. 10.1155\/2013\/256280","journal-title":"Sarcoma"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi A","year":"2021","unstructured":"Gronchi A, Miah AB, Dei Tos AP, et al.. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021, 32:1348-65. 10.1016\/j.annonc.2021.07.006","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11766","article-title":"Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy","volume":"34","author":"Chamberlain F","year":"2020","unstructured":"Chamberlain F, Engelmann B, Al-Muderis O, et al.. Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy. In Vivo. 2020, 34:239-45. 10.21873\/invivo.11766","journal-title":"In Vivo"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.103689","article-title":"Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group","volume":"9","author":"Giani C","year":"2024","unstructured":"Giani C, Denu RA, Ljevar S, et al.. Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group. ESMO Open. 2024, 9:103689. 10.1016\/j.esmoop.2024.103689","journal-title":"ESMO Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465733-recurrent-intra-abdominal-low-grade-fibromyxoid-sarcoma-managed-with-multivisceral-resections-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:10:13Z","timestamp":1776269413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465733-recurrent-intra-abdominal-low-grade-fibromyxoid-sarcoma-managed-with-multivisceral-resections-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.107100","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}